Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes

By K. Klausen, K. Borch-Johnsen, B. Feldt-Rasmussen, Gorm B. Jensen, P. Clausen, H. Scharling, M. Appleyard, Jan Skov Jensen. Circulation, 2004

736 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Standards of Medical Care in Diabetes—2008 (2008, background): “Microalbuminuria is also a well-established marker of increased CVD risk (191,192).”
Standards of Medical Care in Diabetes—2009 (2009, background): “Microalbuminuria is also a well-established marker of increased CVD risk (226,227).”
Standards of Medical Care in Diabetes–2006 (2006, background): “Microalbuminuria is also a well-established marker of increased CVD risk (145,146).”
Standards of Medical Care in Diabetes—2012 (2011, positive): “Microalbuminuria is also a well-established marker of increased CVD risk (101,102).”
The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. (2011, neutral): “coronary disease and mortality at very low levels of albumin excretion independent of other risk factors including hypertension and diabetes.(132) Such levels of albuminuria”
Bisphenol A and human health: a review of the literature. (2013, positive): “It is an indicator of endothelial dysfunction in the kidneys, and is a predictor of type-2 9 diabetes and cardiovascular disease [151, 152].”
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? (2008, neutral): “Because this risk seems to be independent of the risk associated with impaired kidney function, the pathogenetic mechanisms may be different (86).”